Wealth Enhancement Trust Services Inc. acquired a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 24,192 shares of the company's stock, valued at approximately $3,467,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Pekao Towarzystwo Funduszy Inwestycyjnych S.A. acquired a new stake in Procter & Gamble during the 4th quarter valued at $2,712,000. MASTERINVEST Kapitalanlage GmbH lifted its position in shares of Procter & Gamble by 5.5% in the fourth quarter. MASTERINVEST Kapitalanlage GmbH now owns 98,638 shares of the company's stock valued at $14,209,000 after acquiring an additional 5,177 shares in the last quarter. Ninety One UK Ltd boosted its stake in shares of Procter & Gamble by 5.2% during the fourth quarter. Ninety One UK Ltd now owns 250,978 shares of the company's stock valued at $35,968,000 after acquiring an additional 12,496 shares during the last quarter. Stillwater Wealth Management Group increased its position in Procter & Gamble by 17.3% during the 4th quarter. Stillwater Wealth Management Group now owns 2,333 shares of the company's stock worth $334,000 after purchasing an additional 344 shares in the last quarter. Finally, Werba Rubin Papier Wealth Management increased its position in Procter & Gamble by 35.2% during the 4th quarter. Werba Rubin Papier Wealth Management now owns 3,066 shares of the company's stock worth $439,000 after purchasing an additional 799 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Analyst Ratings Changes
A number of research analysts have issued reports on PG shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Procter & Gamble from $171.00 to $162.00 and set a "hold" rating on the stock in a report on Monday, March 30th. Dbs Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating in a research report on Friday, January 23rd. JPMorgan Chase & Co. reduced their price objective on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating on the stock in a research note on Friday. BNP Paribas Exane decreased their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an "outperform" rating on the stock in a research report on Friday, January 16th. Finally, Raymond James Financial lowered their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a research note on Tuesday, April 14th. Twelve analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $163.00.
Read Our Latest Research Report on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of Procter & Gamble stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the transaction, the chief executive officer owned 34,994 shares in the company, valued at $5,680,576.02. This trade represents a 50.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Balaji Purushothaman sold 12,827 shares of the company's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total value of $2,056,296.37. Following the sale, the insider owned 12,639 shares of the company's stock, valued at approximately $2,026,158.09. The trade was a 50.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 348,618 shares of company stock worth $55,462,643 over the last 90 days. Company insiders own 0.20% of the company's stock.
Procter & Gamble Stock Up 2.8%
PG opened at $147.05 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $170.99. The business has a 50-day moving average of $151.80 and a two-hundred day moving average of $148.93. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. The stock has a market capitalization of $341.74 billion, a price-to-earnings ratio of 21.79, a price-to-earnings-growth ratio of 5.51 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the prior year, the firm posted $1.88 EPS. The company's revenue was up 1.5% on a year-over-year basis. On average, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be paid a dividend of $1.0885 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Friday, April 24th. Procter & Gamble's payout ratio is 64.44%.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G reaffirmed its shareholder-return commitment — 70th consecutive dividend increase and plans to return ~$15B in 2026 ($10B dividends, $5B buybacks), supporting income investors and buyback-driven EPS. P&G Raised Its Dividend
- Positive Sentiment: JPMorgan maintained an Overweight rating after trimming its price target to $162 (still >10% upside), signaling institutional confidence despite the small PT cut. JPMorgan Adjusts Price Target
- Positive Sentiment: Category tailwinds: research flags the fragrance-diffuser market expanding in 2026 with P&G named among leaders — incremental growth opportunity in home/eco and smart‑home subsegments. Fragrance Diffuser Market Report
- Positive Sentiment: Some bullish analysts expect P&G’s upcoming earnings to spur a rally — arguments include easier back‑half comps, potentially beatable guide and attractive cash yields that could attract buyers on any positive print. Earnings Can Spur A Rally
- Neutral Sentiment: Consensus expects earnings growth next week, but models show P&G may lack the “right combination” for a clean beat — set your expectations for a mixed print and watch management commentary. Zacks: Reports Next Week
- Neutral Sentiment: Pre-earnings views: sales and EPS are expected to rise, but tariffs, commodity costs and a premium valuation could pressure margins — near‑term execution and guide matter. Zacks: Pre-Q3 Earnings
- Negative Sentiment: P&G warned shareholders about a low‑priced unsolicited mini‑tender from Potemkin Limited and urged rejection — such offers can create short‑term selling pressure or confusion among retail holders. Mini-Tender Warning
- Negative Sentiment: Valuation remains a debate: several analysts and articles flag P&G trading near ~20x earnings and some trims to price targets (RBC lowered its target to $167), leaving some investors on the sidelines despite solid fundamentals. Valuation Keeps Me On Hold Investing.com: Valuation Debate RBC Trimmed Target
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report